Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S Common Stock
(NY:
NVO
)
49.11
-0.35 (-0.71%)
Official Closing Price
Updated: 6:30 PM EST, Nov 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novo Nordisk A/S Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Pfizer Plummets as Key Obesity Drug Candidate Faces Major Setback, Shaking Investor Confidence
September 30, 2025
New York, NY – September 30, 2025 – Shares of pharmaceutical giant Pfizer (NYSE: PFE) experienced a dramatic decline today, making it one of the market's bottom performers, following an unexpected and...
Via
MarketMinute
Topics
Intellectual Property
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
September 30, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
Trump's Plan To Lower U.S. Drug Prices Faces Big Test
September 30, 2025
But Trump might get less than he bargained for as drugmakers focus on prices abroad, rather than stateside efforts.
Via
Investor's Business Daily
Topics
Government
LifeMD Offers Novo Nordisk’s Ozempic For $499 A Month To Eligible Patients
September 30, 2025
Via
Stocktwits
Why Wegovy Maker Novo Nordisk’s Stock Is Sliding 3% Premarket Today
September 29, 2025
Via
Stocktwits
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Novo Nordisk A/S (NVO) Shareholders
September 30, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Novo Nordisk A/S (NVO) Shareholders
September 30, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Why Is Novo Nordisk Stock Down in 2025, and Is It a Buying Opportunity?
September 30, 2025
Political pressure on Big Pharma is one reason why the industry is underperforming in 2025.
Via
The Motley Fool
These 2 Top Dividend Stocks Are Finally Rebounding, and There Might Be More Upside Ahead
September 30, 2025
It's hard to keep these longtime winners down for too long.
Via
The Motley Fool
Topics
Artificial Intelligence
Government
World Trade
Why Novo Nordisk Stock Slumped on Monday
September 29, 2025
A pundit tracking the company cited several reasons why investors should sell out of it.
Via
The Motley Fool
Topics
World Trade
Deadline Soon: Novo Nordisk A/S (NVO) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
September 29, 2025
From
The Law Offices of Frank R. Cruz
Via
Business Wire
NOVO URGENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Novo Nordisk Investors to Contact the Firm Before September 30th
September 29, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Contact Levi & Korsinsky by September 30, 2025 Deadline to Join Class Action Against Novo Nordisk A/S (NVO)
September 29, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Contact Levi & Korsinsky by September 30, 2025 Deadline to Join Class Action Against Novo Nordisk A/S (NVO)
September 29, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
September 29, 2025
U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Monday. Shares of Inventiva ADR (NASDAQ: IVA) fell sharply in today's pre-market trading following H1...
Via
Benzinga
Topics
Stocks
3 Magnificent Stocks Under $100 to Buy Right Now
September 27, 2025
You won't need a huge amount of cash to invest in these great pharma stocks.
Via
The Motley Fool
Global Markets Brace for Impact as New U.S. Tariffs Escalate Trade Tensions Amidst Geopolitical Volatility
September 26, 2025
September 26, 2025 – Global financial markets are once again in the throes of uncertainty as the United States unveils a fresh wave of substantial trade tariffs, set to take effect on October 1, 2025....
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Emissions
Investors Who Lost Money on Novo Nordisk A/S (NVO) Should Contact Levi & Korsinsky About Pending Class Action - NVO
September 26, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Investors Who Lost Money on Novo Nordisk A/S (NVO) Should Contact Levi & Korsinsky About Pending Class Action - NVO
September 26, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Novo Nordisk A/S Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – NVO
September 26, 2025
From
DJS Law Group
Via
Business Wire
Consumers Splurge, Intel, GlobalFoundries, Lilly, Paccar, American Woodmark Benefit From New Tariffs
September 26, 2025
To gain an edge, this is what you need to know today.
Via
Benzinga
NOVO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Novo Nordisk Investors to Contact the Firm Before September 30th
September 26, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet
September 26, 2025
Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creating clear stock market winners like Eli Lilly while foreign-de
Via
Benzinga
Topics
Government
World Trade
Eli Lilly's GLP-1 Pill Just Beat Out Novo Nordisk's in a Test. Here's 1 Thing Investors Need to Know.
September 26, 2025
Recent data from a head-to-head trial was positive for Eli Lilly, but it's not the whole story.
Via
The Motley Fool
3 Absurdly Cheap Stocks You Can Buy for Less than $100 Right Now
September 26, 2025
These stocks come with some uncertainty, but they have strong fundamentals and trade at low earnings multiples.
Via
The Motley Fool
Topics
World Trade
Trump Shocks Pharma With 100% Tariff On Imported Drugs Unless Companies Build In America
September 25, 2025
Via
Stocktwits
Topics
Government
Faruqi & Faruqi Reminds Novo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 - NVO
September 25, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Lost Money on Novo Nordisk A/S (NVO)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
September 25, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Lost Money on Novo Nordisk A/S (NVO)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
September 25, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Does This Acquisition Make Pfizer Stock a Great Buy?
September 25, 2025
There's an opportunity to get in on the weight-loss drug craze at a reasonable price.
Via
The Motley Fool
Topics
Death
Intellectual Property
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.